Physician

Jonathan Heng Tzu, MD

According to 2025 Medicare claims, Jonathan Tzu, MD (NPI: 1962630335) practices ophthalmology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is RETINA AND VITREOUS OF TEXAS PLLC (NPI: 1003892597; TIN: 760534711) and primary practice location at 77375-4688. Tzu is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Tzu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 812 traditional Medicare patients, billed 42,807 HCPCS/CPT codes, and received $3,174,237 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 567 prescription claims across 149 beneficiaries totaling $17,157 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 22 records totaling $950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $148,330 to $3,174,237. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	326	1,422	$148,330
2016	731	9,490	$969,897
2017	758	10,957	$1,181,144
2018	746	11,968	$1,479,637
2019	852	14,436	$2,032,265
2020	798	13,662	$2,216,327
2021	785	13,654	$2,374,389
2022	802	16,670	$2,670,576
2023	830	31,977	$2,898,586
2024	812	42,807	$3,174,237

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	62	175	$19,513
2016	99	255	$15,957
2017	147	390	$19,880
2018	151	485	$18,146
2019	158	528	$23,193
2020	166	469	$23,471
2021	153	479	$32,282
2022	150	542	$31,707
2023	166	593	$27,383
2024	149	567	$17,157

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	345	1,886	$90
92014	Established patient complete exam of visual system	710	2,045	$84
92134	Imaging of retina	806	2,668	$29
92201	Extended exam of the back part of the eye with retinal drawing	315	675	$18
92202	Extended exam of the back part of the eye with optic nerve drawing	402	1,436	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	143	6,271	$6,737
Ketorolac Tromethamine	Ketorolac Tromethamine	82	3,561	$1,850
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	79	5,176	$1,107
Latanoprost	Latanoprost	101	3,197	$849
Ofloxacin	Ofloxacin	73	1,579	$803

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$950	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$11,926	US Retina LLC

Explore More Providers

FAQ

What Medicare data is available for Jonathan Heng Tzu, MD?

Tedicare shows public-source Medicare data for Jonathan Heng Tzu, MD (NPI 1962630335), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Heng Tzu, MD have ACO affiliation data?

Jonathan Heng Tzu, MD is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Jonathan Heng Tzu, MD?

Jonathan Heng Tzu, MD is linked to RETINA AND VITREOUS OF TEXAS PLLC (billing NPI 1003892597) in the available physician profile data.

Does Jonathan Heng Tzu, MD have Open Payments data?

Jonathan Heng Tzu, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.